Skip to main content

Table 1 Main characteristics of the studies included in this analysis

From: Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis

Study (year)

Country

Study design

Period(y)

Participants (pregnancies)

Maternal outcomes

Fetal outcomes

NOS score

Ruffatti 2016 [8]

Italy

retrospective

2009–2014

12(12)

type of delivery, pregnancy complications, gestational period (weeks), preterm labor

5 min APGAR score, neonatal complications, birth weight, cardiac complications, NICU admission, small for gestational age

******

Zuppa 2008 [9]

Italy

retrospective

2004–2005

10(10)

type of delivery, gestational period (weeks), preterm labor

live birth, birth weight, hematologic manifestation, echoencephalographic abnormalities, liver manifestations

******

Morel 2017 [10]

France

–

2000–2014

174(187)

gestational period (weeks), preterm labor

fetal death /perinatal death, birth weight, DCM, EFE, hydrops, Pericardial effusion, congenital heart disease, pacemaker implantation

*****

Cimaz 2003 [11]

Canada

prospective

1987–2000

112(128)

preterm labor

live birth, type of block, skin manifestations, hematologic manifestation, liver manifestations, prolonged QT interval, CHB recurrence, hematological and hepatic manifestations

******

Boros 2007 [12]

Canada

–

1999–2004

75(87)

–

type of block, hydrocephalus, cutaneous involvement, hematologic and/or liver enzyme abnormalities, hematological and hepatic manifestations

******

Miniaoui 2022 [13]

France

–

2000–2019

215(215)

terminations of pregnancy, disease-free survival probability at 5 years and 10 years, the probability of developing SLE/SS, the estimated median time to progression

fetal death /perinatal death, live birth

******

Gladman 2002 [14]

Canada

prospective

1988–1997

105(118)

spontaneous abortion

intrauterine deaths, DCM, type of block, peripheral pulmonary artery stenosis, CHB recurrence

******

Pisoni 2010 [15]

Italy

prospective

2004–2008

22(24)

terminations of pregnancy

type of block, cutaneous involvement, CHB recurrence

******

Skog 2015 [16]

Sweden

prospective

2000–2013

155(212)

type of delivery, preterm labor, preeclampsia

fetal death /perinatal death, type of block, CHB recurrence, neonatal complications

*****

Jaeggi 2010 [7]

Canada

prospective

2000–2008

164(186)

termination of pregnancy

intrauterine death, type of block, endocardial fibroelastosis, hydrops, pericardial effusion, CHB recurrence, hematological and hepatic manifestations

******

Sonesson 2004 [17]

Sweden

–

1999–2003

24(24)

preterm labor

type of block

********

Kan 2017 [18]

Canada

retrospective

2009–2014

189(195)

maternal eclampsia

intrauterine death, pacemaker implantation, type of block, endocardial fibroelastosis, pericardial effusion, congenital heart disease, CHB recurrence

******

Bergman 2012 [19]

Sweden

crosssectional follow-up

1999–2007

48(57)

–

type of block

*****

Gerosa 2007 [20]

Italy

prospective

2000–2004

60(60)

spontaneous abortion, preterm labor

pacemaker implantation,1 min APGAR score, type of block

********

Motta 2007 [21]

Italy

prospective

1999–2005

43(51)

–

type of block

******

Chalumeau 2004 [22]

France

–

1991–2002

106(167)

spontaneous abortion, terminations of pregnancy, preterm labor

IUGR,fetal death /perinatal death,live birth,type of block, congenital defects

********

Brucato 2002 [23]

Italy

prospective

–

100(126)

type of delivery, ectopic pregnancy, spontaneous abortion, preeclampsia, pregnancy complications, preterm labor

live birth, small for gestational age, type of block, IUGR

********

Briassouli 2013 [24]

USA

retrospective

–

61(61)

type of delivery

–

*****